Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca D'Aversa

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Gastroenterology|July 10, 2020
Antibiotic Prophylaxis for Endoscopic Ultrasound-Guided Diagnostic Interventions on Pancreatic Cysts: A Never-Ending StoryEdoardo Troncone, Francesca D'Aversa, Alberto Larghi
Giornale Italiano Di Cardiologia (2006)|February 23, 2016
[The relationship between gut microbiota and cardiovascular diseases]Viviana Gerardi, Fabio Del Zompo, Francesca D'Aversa, et al.
Digestive Diseases (Basel, Switzerland)|April 16, 2014
Nutrients affecting gastric barrierAntonio Gasbarrini, Francesca D'Aversa, Teresa Di Rienzo, et al.
World Journal of Gastroenterology|July 26, 2017
Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulationFrancesca Romana Ponziani, Maria Assunta Zocco, Francesca D'Aversa, et al.
Internal and Emergency Medicine|March 8, 2013
Gut microbiota and metabolic syndromeFrancesca D'Aversa, Annalisa Tortora, Gianluca Ianiro, et al.
World Journal of Gastroenterology|June 8, 2013
Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantationFrancesca Romana Ponziani, Eleonora Brigida Annicchiarico, Massimo Siciliano, et al.
World Journal of Gastroenterology|October 11, 2012
What we should know about portal vein thrombosis in cirrhotic patients: a changing perspectiveFrancesca Romana Ponziani, Maria Assunta Zocco, Matteo Garcovich, et al.
World Journal of Gastroenterology|November 26, 2015
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complicationsFrancesca Romana Ponziani, Viviana Gerardi, Silvia Pecere, et al.
Current Pharmaceutical Design|November 5, 2013
Role of yeasts in healthy and impaired gut microbiota: the gut mycomeGianluca Ianiro, Giovanni Bruno, Loris Lopetuso, et al.
International Journal of Molecular Sciences|August 1, 2018
Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the LiverLoris Riccardo Lopetuso, Giammarco Mocci, Manuela Marzo, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Gastroenterology|July 10, 2020
Antibiotic Prophylaxis for Endoscopic Ultrasound-Guided Diagnostic Interventions on Pancreatic Cysts: A Never-Ending StoryEdoardo Troncone, Francesca D'Aversa, Alberto Larghi
Giornale Italiano Di Cardiologia (2006)|February 23, 2016
[The relationship between gut microbiota and cardiovascular diseases]Viviana Gerardi, Fabio Del Zompo, Francesca D'Aversa, et al.
Digestive Diseases (Basel, Switzerland)|April 16, 2014
Nutrients affecting gastric barrierAntonio Gasbarrini, Francesca D'Aversa, Teresa Di Rienzo, et al.
World Journal of Gastroenterology|July 26, 2017
Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulationFrancesca Romana Ponziani, Maria Assunta Zocco, Francesca D'Aversa, et al.
Internal and Emergency Medicine|March 8, 2013
Gut microbiota and metabolic syndromeFrancesca D'Aversa, Annalisa Tortora, Gianluca Ianiro, et al.
World Journal of Gastroenterology|June 8, 2013
Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantationFrancesca Romana Ponziani, Eleonora Brigida Annicchiarico, Massimo Siciliano, et al.
World Journal of Gastroenterology|October 11, 2012
What we should know about portal vein thrombosis in cirrhotic patients: a changing perspectiveFrancesca Romana Ponziani, Maria Assunta Zocco, Matteo Garcovich, et al.
World Journal of Gastroenterology|November 26, 2015
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complicationsFrancesca Romana Ponziani, Viviana Gerardi, Silvia Pecere, et al.
Current Pharmaceutical Design|November 5, 2013
Role of yeasts in healthy and impaired gut microbiota: the gut mycomeGianluca Ianiro, Giovanni Bruno, Loris Lopetuso, et al.
International Journal of Molecular Sciences|August 1, 2018
Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the LiverLoris Riccardo Lopetuso, Giammarco Mocci, Manuela Marzo, et al.
Pageof 2